The European Commission proposed Chips Act 2.0 on June 3, targeting €120 billion in semiconductor investment by 2035, more than double the €52 billion mobilised under the original act. The revision introduces an excellence label for chip regions, deepens AI-component policy, and arrives as European fabs remain largely unbuilt while the global market accelerates toward €1.37 trillion by 2030.
Biotech & Life Sciences
EU Biotech Act at Midpoint
FAST-EU, the voluntary pilot for accelerated multinational clinical trials, is six months in, targeting approval decisions within 70 days of submission. Trilogue on the broader Biotech Act is not expected before Q4 2026, leaving a gap between the reform's ambitions and when it actually takes effect.
The act's deeper bet is enabling AI in clinical trial design, targeting 80-90% cuts in development costs. The technical standards that would make this real do not yet exist. (Clifford Chance)
Isomorphic Labs Approaches First Human Trials
London-based Isomorphic Labs, which raised $2.1 billion in May, is "getting very close" to dosing patients in Phase 1 trials for AI-designed oncology candidates. If it succeeds before year-end, Isomorphic becomes the first AI-native company to advance a self-designed drug from its own pipeline into the clinic. (Clinical Trials Arena)
Quantum & Photonics
SOL Inaugurated in Bologna
EuroHPC and INFN inaugurated SOL in Bologna on June 11: a 140-qubit neutral-atom Pasqal QPU integrated with the Leonardo pre-exascale supercomputer. It is Italy's first neutral-atom quantum computer and Pasqal's third EuroHPC-linked system in Europe, after installations in Germany and France.
The €13 million system is co-funded equally by EuroHPC and Italy's Ministry of University and Research, adding another node to the hybrid classical-quantum infrastructure Europe is assembling across multiple host sites. (HPCwire)
$961 Million in Seven Days
Four European quantum companies raised $961 million in a single week in early June. Oxford Quantum Circuits and OQC each closed rounds above $350 million; IQM of Finland upsized a PIPE to $146 million ahead of a planned dual-exchange listing; Grenoble's Quobly raised $115 million for its sapphire-based superconducting qubit approach.
The pace confirms capital is now available at scale for European quantum. Whether European companies can build manufacturing capacity before US and Asian competitors consolidate remains an open question. (StartupHub.ai)
Space
Parmitano Assigned to Artemis III
NASA named ESA astronaut Luca Parmitano as test pilot for Artemis III on June 9, the first European assigned to a crewed Artemis mission. The flight will demonstrate systems required for future lunar landing missions from Artemis IV onwards.
ESA is providing the Orion Service Module for the mission. For ESA, the assignment marks a first crew seat in the programme, not just a hardware contribution. (ESA)
European Launchers at ILA Berlin
The Berlin International Airshow (June 10-14) put Europe's commercial launcher ecosystem on display alongside Ariane 6. ESA's Launcher Challenge has committed over €900 million to five companies including PLD Space, Isar Aerospace, and Rocket Factory Augsburg, with inaugural orbital flights still pending for all of them.
Capital is committed across five companies; none has reached orbit yet. That is the live question for European commercial space in 2026. (ESA)
Robotics & Automation
NEURA Robotics Raises $1.4 Billion
Germany's NEURA Robotics closed a Series C of up to $1.4 billion on June 10 at a $7 billion valuation, backed by Nvidia, Amazon, Tether, Bosch, and the European Investment Bank. The company targets serial production of millions of cognitive robots by 2030.
The EIB's participation signals that European policymakers have decided physical AI is an industrial competitiveness matter, not just a venture story. (The Robot Report)
Semiconductors
What Changes in Chips Act 2.0
The June 3 proposal goes beyond the original act's fabrication focus, adding demand-side measures and an excellence label for semiconductor clusters intended to coordinate Member State investment. The €120 billion 2035 target assumes continued private co-investment; the original act mobilised €52 billion while creating 46,000 jobs.
The next constraint is not political will but execution: permitting speed, workforce supply, and closing the design-talent gap before AI-driven chip demand reshapes what gets built where. (AENEAS)
One to Watch
IQM's Dual Exchange Listing
Finland's IQM is preparing simultaneous listings on Nasdaq and Nasdaq Helsinki, which would make it the first European quantum hardware company trading on both exchanges. A completed listing in 2026 would create a precedent for European deep tech companies accessing US institutional capital without relocating.
The timeline depends on SEC review and market conditions for the rest of the year. (StartupHub.ai)